DALLAS (AP) -- The first trial over heart-valve damage from fen-phen has ended in a reported $500,000 settlement for a woman who used the diet drug combination.
The settlement came a week into Sandra Moore's case against the pharmaceutical giant American Home Products Corp.
The 52-year-old former teacher had sought $110 million.
American Home said today it had agreed to a settlement but offered no details.
Doctors found mild heart valve damage in Ms. Moore after she took fen-phen to promote weight loss, and she is on medication for her condition.
The Madison, N.J.-based drug maker pulled fenfluramine and Redux off the market in 1997 at the Food and Drug Administration's request.
PHILADELPHIA -- Opponents of the proposed $3.75 billion fen-phen settlement vowed Thursday to appeal if the deal is not rejected by a federal judge.
''If we allow this to go forward, there will be a substantial risk it will be reversed and we will have wasted time'' that could have been better spent attending to users' health needs, Blizzard said during his final summation.
More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the ''fen'' in the fen-phen diet drug combination.
The drugs were withdrawn in September 1997 after a Mayo Clinic study linked fen-phen to potentially fatal heart valve damage.
Opponents say monetary damages are insufficient, the settlement does not include compensation for people who may develop health problems later and users had inadequate representation.
HOUSTON (AP) -- The manufacturer of the
